Frontal cognitive impairments and saccadic deficits in low-dose MPTP- treated monkeys

Journal of Neurophysiology

Volumn 81, Issue 2, 1999, Pages 858-874

  Slovin, Hamutal ^b   Abeles, Moshe ^a   Vaadia, Eilon ^a   Haalman, Iris ^c   Prut, Yifat ^c   Bergman, Hagai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; MONKEY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; TASK PERFORMANCE;

EID: 0033031356     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1999.81.2.858     Document Type: Article

References (75)

1. APICELLA, P., LEGALLET, E., NIEOULLON, A., AND TROUCHE, E. Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion. Behav. Brain Res. 46: 187-195, 1991.
2. ASCHOFF, J. C., BECKER, W., AND WEINERT, D. Computer analysis of eye movements: evaluation of the state of alterness and vigilance after Sulpride medication. J. Pharmacol. Clin. 2: 93-97, 1975.
3. BANKIEWICZ, K. S., OLDFIELD, E. H., PLUNKETT, R. J., SCHUETTE, W. H., COGAN, D. G., HOGAN, N., ZUDDAS, A., AND KOPIN, I. J. Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion. Brain Res. 541: 98-102, 1991.
4. BECKER, W. Metrics. In: The Neurobiology of Saccadic Eye Movements, edited by R. H. Wurtz and M. E. Goldberg. Amsterdam: Elsevier, 1989, p. 13-67.
5. BERGMAN, H., WICHMANN, T., KARMON, B., AND DELONG, M. R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 72: 507-520, 1994.
6. BOLAM, J. P. Experimental Neuroanatomy: A Practical Approach. Oxford: IRL Press, 1992.
7. BROOKS, B. A., FUCHS, A. F., AND FINOCCHIO, D. Saccadic eye movement deficits in the MPTP monkey model of Parkinson's disease. Brain Res. 383: 402-407, 1986.
8. BROWN, R. G. AND MARSDEN, C. D. An investigation of the phenomenon of "set" in Parkinson's disease. Movement Disorders 3: 152-161, 1988.
9. BROWN, R. G. AND MARSDEN, C. D. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci. 13: 21-29, 1990.
10. BROZOSKI, T. J., BROWN, R. M., ROSVOLD, H. E., AND GOLDMAN, P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-932, 1979.
11. BRUCE, C. J. AND GOLDBERG, M. E. Primate frontal eye fields. I. Single neurons discharging before saccades. J. Neurophysiol. 53: 603-635, 1985.
12. BURNS, R. S., CHIUEH, C. C., MARKEY, S. P., EBERT, M. H., JACOBOWITZ, D. M., AND KOPIN, I. J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80: 4546-4550, 1983.
13. CHARLES, L., SCHAIN, R. J., ZELNIKER, T., AND GUTHRIE, D. Effects of methylphenidate on hyperactive children's ability to sustain attention. Pediatrics 64: 412-418, 1979.
14. COOPER, J. A., SAGAR, H. J., JORDAN, N., HARVEY, N. S., AND SULLIVAN, E. V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114: 2095-2122, 1991.
15. DE LANCY HORNE, D. J. Performance on delayed response tasks by patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry 34: 192-194, 1971.
16. DELONG, M. R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13: 281-528, 1990.
17. FERNANDEZ RUIZ, J., DOUDET, D. J., AND AIGNER, T. G. Long-term cognitive impairment in MPTP-treated rhesus monkeys. Neuroreport 7: 102-104, 1995.
18. FILION, M. AND TREMBLAY, L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547: 142-151, 1991.
19. FLOWERS, K. A. AND ROBERTSON, C. The effect of Parkinson's disease on the ability to maintain a mental set. J. Neurol. Neurosurg. Psychiatry 48: 517-529, 1985.
20. FUSTER, J. M. The Prefrontal Cortex Anatomy, Physiology, and Neuropsychology of the Frontal Lobes (3rd ed.). New York: Lippincott-Raven, 1997.
21. GEMBA, H. AND SASAKI, K. Potential related to no-go reaction in go/no-go hand movement with discrimination between tone stimuli of different frequencies in the monkey. Brain Res. 537: 340-344, 1990.
22. GOTHAM, A. M., BROWN, R. G., AND MARSDEN, C. D. "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 111: 299-321, 1988.
23. HANTRAYE, P., VARASTET, M., PESCHANSKI, M., RICHE, D., CESARO, P., WILLER, J. C., AND MAZIERE, M. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons. Neuroscience 53: 169-178, 1993.
24. HOTSON, J. R., LANGSTON, E. B., AND LANGSTON, J. W. Saccade responses to dopamine in human MPTP-induced parkinsonism. Ann. Neurol. 20: 456-463, 1986.
25. IVERSEN, S. D. AND MISHKIN, M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp. Brain Res. 11: 376-386, 1970.
26. JAHANSHAHI, M., JENKINS, I. H., BROWN, R. G., MARSDEN, C. D., PASSINGHAM, R. E., AND BROOKS, D. J.Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118: 913-933, 1995.
27. JENNER, P., ROSE, S., NOMOTO, M., AND MARSDEN, C. D. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects. Adv. Neurol. 45: 183-190, 1986.
28. KATO, M., MIYASHITA, N., HIKOSAKA, O., MATSUMURA, M., USUI, S., AND KORI, A. Eye movements in monkeys with local dopamine depletion in the caudate nucleus, I. Deficits in spontaneous saccades. J. Neurosci. 15: 912-927, 1995.
29. KONIGSMARK, B. W. Methods for the counting of Neurons. In: Contemporary Research Methods in Neuroanatomy, edited by W.J.H. Nauta and S.O.E. Ebbesson. New York: Springer-Verlag, 1970, p. 315-340.
30. KORI, A., MIYASHITA, N., KATO, M., HIKOSAKA, O., USUI, S., AND MATSUMURA, M. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. II. Deficits in voluntary saccades. J. Neurosci. 15: 928-941, 1995.
31. LABUTTA, J. L., MILES, R. B., SANES, J. N., AND HALLET, M. Motor program memory storage in Parkinson's disease patients tested with a delayed response task. Movement Disorders 9: 218-222, 1994.
32. LANGE, K. W., ROBBINS, T. W., MARSDEN, C. D., JAMES, M., OWEN, A. M., AND PAUL, G. M. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107: 394-404, 1992.
33. LEVIN, B. E., LLABRE, M. M., AND WEINER, W. J. Cognitive impairments associated with early Parkinson's disease. Neurology 39: 557-561, 1989.
34. LEVIN, H. S., EISENBERG, H. M., AND BENTON, A. L. Frontal Lobe Function and Dysfunction. New York: Oxford, 1991.
35. LUECK, C. J., CRAWFORD, T. J., HENDERSON, L., VAN GISBERGEN, J. A., DUYSENS, J., AND KENNARD, C. Saccadic eye movements in Parkinson's disease. II. Remembered saccades - towards a unified hypothesis?. Q. J. Exp. Psychol. A 45: 211-233, 1992a.
36. LUECK, C. J., TANYERI, S., CRAWFORD, T. J., HENDERSON, L., AND KENNARD, C. Saccadic eye movements in Parkinson's disease. I. Delayed saccades. Q. J. Exp. Psychol. A 45: 193-210, 1992b.
37. MANDIR, A. S. AND WATTS, R. L. Changes in primary motor cortex neuronal activity associated with increased reaction time and movement time in MPTP parkinsonism. Movement Disorders 5, Suppl.: 1-77, 1990.
38. MOHR, E., JUNCOS, J., COX, C., LITVAN, I., FEDIO, P., AND CHASE, T. N. Selective deficits in cognition and memory in high-functioning Parkinsonian patients. J. Neurol. Neurosurg. Psychiatry 53: 603-606, 1990.
39. NAKAMURA, T., KANAYAMA, R., SANO, R., OHKI, M., KIMURA, Y., AOYAGI, M., AND KOIKE, Y. Quantitative analysis of ocular movements in Parkinson's disease. Acta Otolaryngol. Suppl. Stockh. 481: 559-562, 1991.
40. OWEN, A. M., JAMES, M., LEIGH, P. N., SUMMERS, B. A., MARSDEN, C. D., QUINN, N. P., LANGE, K. W., AND ROBBINS, T. W. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115: 1727-1751, 1992.
41. OWEN, A. M., ROBERTS, A. C., HODGES, J. R., SUMMERS, B. A., POLKEY, C. E., AND ROBBINS, T. W. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116: 1159-1175, 1993.
42. OWEN, A. M., ROBERTS, A. C., POLKEY, C. E., SAHAKIAN, B. J., AND ROBBINS, T. W. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalohippocampectomy in man. Neuropsychologia 29: 993-1006, 1991.
43. PASCUAL LEONE, A. AND HALLETT, M. Induction of errors in a delayed response task by repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuroreport 5: 2517-2520, 1994.
44. PASSINGHAM, R. The Frontal Lobes and Voluntary Action. New York: Oxford, 1993.
45. PELHAM, W. E., BENDER, M. E., CADDELL, J., BOOTH, S., AND MOORER, S. H. Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior. Arch. Gen. Psychiatry 42: 948-952, 1985.
46. PEREZ OTANO, I., OSET, C., LUQUIN, M. R., HERRERO, M. T., OBESO, J. A., AND DEL RIO, J. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Neurosci. Lett. 175: 121-125, 1994.
47. PIFL, C., SCHINGNITZ, G., AND HORNYKIEWICZ, O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 44: 591-605, 1991.
48. PLAYFORD, E. D., JENKINS, I. H., PASSINGHAM, R. E., NUTT, J., FRACKOWIAK, R. S., AND BROOKS, D. J. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann. Neurol. 32: 151-161, 1992.
49. POIRIER, L. J., GIGUERE, M., AND MARCHAND, R. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res. Bull. 11: 371-397, 1983.
50. PULLMAN, S. L., WATTS, R. L., JUNCOS, J. L., CHASE, T. N., AND SANES, J. N. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology 38: 249-254, 1988.
51. QWEN, A. M., BEKSINSKA, M., JAMES, M., LEIGH, P. N., SUMMERS, B. A., MARSDEN, C. D., QUINN, N. P., SAHAKIAN, B. J., AND ROBBINS, T. W. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologica 31: 627-644, 1993.
52. RASCOL, O., CLANET, M., MONTASTRUC, J. L., SIMONETTA, M., SOULIER EsTEVE, M. J., DOYON, B., AND RASCOL, A. Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. Brain 112: 1193-1214, 1989.
53. RASKIN, S. A., BOROD, J. C., AND TWEEDY, J. R. Set-shifting and spatial orientation in patients with Parkinson's disease. J. Clin. Exp. Neuropsychol. 14: 801-821, 1992.
54. RICHARDS, M., COTE, L. J., AND STERN, Y. Executive function in Parkinson's disease: set-shifting or set-maintenance? J. Clin. Exp. Neuropsychol. 15: 266-279, 1993.
55. ROBERTS, A. C., DE SALVIA, M. A., WILKINSON, L. S., COLLINS, P., MUIR, J. L., EVERITT, B. J., AND ROBBINS, T. W. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J. Neurosci. 14: 2531-2544, 1994.
56. ROELTGEN, D. P. AND SCHNEIDER, J. S. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys. Behav. Brain Res. 60: 115-124, 1994.
57. ROTTACH, K. G., RILEY, D. E., DISCENNA, A. O., ZIVOTOFSKY, A. Z., AND LEIGH, R. J. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann. Neurol. 39: 368-377, 1996.
58. SASAKI, K., GEMBA, H., NAMBU, A., AND MATSUZAKJ, R. No-go activity in the frontal association cortex of human subjects. Neurosci. Res. 18: 249-252, 1993.
59. SAWAGUCHI, T. AND GOLDMAN RAKIC, P. S. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251: 947-950, 1991.
60. SCHNEIDER, J. S. AND KOVELOWSKI, C. J., II. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res. 519: 122-128, 1990.
61. SCHNEIDER, J. S. AND ROELTGEN, D. P. Delayed matching-to-sample, object retrieval, and discrimination reverasl deficits in chronic low dose MPTP treated monkeys. Brain Res. 615: 351-354, 1993.
62. SCHNEIDER, J. S., SUN, Z. Q., AND ROELTGEN, D. P. Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys. Pharmacol. Biochem. Behav. 48: 235-240, 1994.
63. SCHULTZ, W., ROMO, R., SCARNATI, E., SUNDSTROM, E., JONSSON, G., AND STUDER, A. Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP-treated monkeys. Exp. Brain Res. 78: 253-267, 1989a.
64. SCHULTZ, W., STUDER, A., ROMO, R., SUNDSTROM, E., JONSSON, G., AND SCARNATI, E. Deficits in reaction times and movement times as correlates of hypokinesia in monkeys with MPTP-induced striatal dopamine depletion. J. Neurophysiol. 61: 651-668, 1989b.
65. SLOVIN, H., ABELES, M., HAALMAN, I., PRUT, Y., VAADIA, E., AND BERGMAN, H. Coginitive impairments and cortical neuronal activity in low dose MPTP treated monkeys. Soc. Neurosci. Abstr. 19: 780, 1993.
66. STAUDE, G., WOLF, W., OTT, M., OERTEL, W. H., AND DENGLER, R. Tremor as a factor in prolonged reaction times of parkinsonian patients. Movement Disorders 10: 153-162, 1995.
67. STERN, Y. AND LANGSTON, J. W. Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 35: 1506-1509, 1985.
68. STERN, Y., TETRUD, J. W., MARTIN, W.R.W., KUTNER, S. J., AND LANGSTON, J. W. Cognitive changes following MPTP exposure. Neurology 40: 261-264, 1990.
69. STUSS, D. T. AND BENSON, D. F. The Frontal Lobes. New York: Raven, 1986.
70. TAYLOR, A. E., SAINT-CYR, J. A., AND LANG, A. E. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 109: 845-883, 1986.
71. TOMER, R., LEVIN, B. E., AND WEINER, W. J. Side of onset of motor symptoms influences cognition in Parkinson's disease. Ann. Neurol. 34: 579-584, 1993.
72. TSAI, C. H., LU, C. S., HUA, M. S., LO, W. L., AND LO, S. K. Cognitive dysfunction in early onset parkinsonism. Acta. Neurol. Scand. 89: 9-14, 1994.
73. WIERZBICKA, M. M., STAUDE, G., WOLF, W., AND DENGLER, R. Relationship between tremor and the onset of rapid voluntary contraction in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 56: 782-787, 1993.
74. WILLIAMS, G. V. AND GOLDMAN RAKIC, P. S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572-575, 1995.
75. YANAGISAWA, N., FUJIMOTO, S., AND TAMARU, F. Bradykinesia in Parkinson's disease: disorders of onset and execution of fast movement. Eur. Neurol. 29, Suppl. 1: 19-28, 1989.